CIK 0001658551 · Non-accelerated filer<br>Smaller reporting company
Amylyx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMLX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464600503
- Phone
- 617-682-0917
- Business address
- 55 CAMBRIDGE PARKWAY, SUITE 6W, CAMBRIDGE, MA, 02142
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Material agreement
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Results of operations
- 8-K Event Acquisition or sale completed
- 8-K Event Material agreement
- 8-K Event Shareholder vote results
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- 8-K Event Other events
- 8-K Event Exit or restructuring costs · Regulation FD disclosure · Other events
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure · Other events
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
Page 2 of 4 · 66 filings